Infantile hemangioma: Treatment with short course systemic corticosteroid therapy as an alternative for propranolol

Pediatric Dermatology

Volumn 30, Issue 1, 2013, Pages 64-70

  Nieuwenhuis, Klaske ^a   De Laat, Peter C J ^a   Janmohamed, Sherief R ^a,b   Madern, Gerard C ^a   Oranje, Arnold P ^a,b,c  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b KinderHaven   (Netherlands)

^c Maasstad Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; PROPRANOLOL;

ACNE; ADRENAL INSUFFICIENCY; APPETITE; ARTICLE; BLOOD PRESSURE; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CUSHING DISEASE; DRUG MEGADOSE; FEMALE; HEMANGIOMA ACTIVITY SCORE; HUMAN; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEMANGIOMA, CAPILLARY; HUMANS; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; PREDNISOLONE; PROPRANOLOL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84872316617     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01846.x     Document Type: Article

References (23)

1. Enjolras O,. Color atlas of vascular tumors and vascular malformations. Paris: Cambridge University Press, 2007.
2. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al., Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
3. Price CJ, Lattouf C, Baum B, et al., Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis. Arch Dermatol 2011; 147: 1371-1376.
4. Hogeling M, Adams S, Wargon O,. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics 2011; 128: e259-e266.
5. Storch CH, Hoeger PH,. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163: 269-274.
6. Sidbury R,. Update on vascular tumors of infancy. Curr Opin Pediatr 2010; 22: 432-437.
7. Lawley LP, Siegfried E, Todd JL,. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26: 610-614.
8. Zvulunov A, McCuaig C, Frieden IJ, et al., Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study. Pediatr Dermatol 2011; 28: 94-98.
9. Bennett ML, Fleischer AB Jr, Chamlin SL, et al., Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001; 137: 1208-1213.
10. Boon LM, MacDonald DM, Mulliken JB,. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999; 104: 1616-1623.
11. Greene AK, Rogers GF, Mulliken JB,. Management of parotid hemangioma in 100 children. Plast Reconstr Surg 2004; 113: 53-60.
12. Greenberger S, Boscolo E, Adini I, et al., Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010; 362: 1005-1013.
13. Bruckner AL, Frieden IJ,. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48: 477-493, quiz 494-476.
14. Delesalle F, Staumont D, Houmany MA, et al., Pulse methylprednisolone therapy for threatening periocular haemangiomas of infancy. Acta Derm Venereol 2006; 86: 429-432.
15. Dourmishev LA, Dourmishev AL,. Craniofacial cavernous hemangioma: successful treatment with methylprednisolone. Acta Dermatovenerol Alp Panonica Adriat 2005; 14: 49-52.
16. George ME, Sharma V, Jacobson J, et al., Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 2004; 140: 963-969.
17. Pope E, Krafchik BR, Macarthur C, et al., Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007; 119: e1239-e1247.
18. Janmohamed SR, de Waard-van der Spek FB, Madern GC, et al., Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS). Clin Exp Dermatol 2011; 36: 715-723.
19. Pokorny JJ, Roth F, Balfour I, et al., An unusual complication of the treatment of a hemangioma. Ann Plast Surg 2002; 48: 83-87.
20. Aviles R, Boyce TG, Thompson DM,. Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas. Mayo Clin Proc 2004; 79: 243-245.
21. Frieden IJ, Haggstrom AN, Drolet BA, et al., Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005; 22: 383-406.
22. Bertrand J, McCuaig C, Dubois J, et al., Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study. Pediatr Dermatol 2011; 28: 649-654.
23. Greenberger S, Boscolo E, Adini I, et al., Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med 2010; 362: 1005-1013.